An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...
In a recent study, talk therapy in Parkinson’s disease led to significant improvement in patients' well-being, ...
The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity.
21h
ThePrint on MSNNo incisions, no pain—AIIMS Delhi 1st govt hospital to treat neuro conditions with ultrasonic beamsMagnetic Resonance-guided Focused Ultrasound tech has the potential to treat conditions like essential tremors & Parkinson’s, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results